659 results about "Trimer" patented technology

This disclosure relates to dimeric immunotherapeutics that comprise two IgGs that are crosslinked with a disulfide bond. The two IgGs may be chimeras of two different heavy chains, in which one heavy chain includes a cysteine mutation that forms the disulfide bond, and the other heavy chain lacks the cysteine mutation. The presence of a cysteine mutation in only one of the heavy chains of an IgG avoids two disulfide bonds between the two IgGs, which increases the accessible orientations between the two crosslinked IgGs, and also avoids the formation of trimers and higher-order oligomers.

The invention provides an anti-aging flame-retardant epoxy resin coating and a preparation process thereof, and belongs to the technical field of coating preparation. The preparation process comprises the following steps: preparing the flame-retardant additive; preparing a coated modified black phosphorus nanosheet; preparing modified hollow glass beads; preparing the epoxy resin coating. The preparation method comprises the following steps: dissolving 3, 4-dihydroxy benzaldehyde and 2-amino-4-methylphenol in absolute ethyl alcohol, carrying out a heating reflux reaction, carrying out dehydration condensation on an aldehyde group in the 3, 4-dihydroxy benzaldehyde and an amino group in the 2-amino-4-methylphenol to generate an imine bond-containing intermediate, respectively dissolving the intermediate and phosphonitrilic chloride trimer, and carrying out a reaction to obtain the phosphonitrilic chloride trimer. The preparation method comprises the following steps: firstly, adding phosphonitrilic chloride into an intermediate, then mixing for reaction, enabling phenolic hydroxyl groups in the intermediate and phosphonitrilic chloride trimer to be subjected to nucleophilic substitution reaction to generate the flame-retardant additive containing phosphorus and a Schiff base structure, and the flame-retardant additive has relatively good compatibility with an epoxy resin matrix, is not easy to separate out and can effectively improve the flame-retardant property of the epoxy resin coating.

The invention relates to an anti-yellowing automobile composite film and a preparation method thereof, and belongs to the technical field of high polymer materials. The yellow-resistant automobile composite film is prepared from the following components in parts by weight: 60 to 70 parts of PVC (Polyvinyl Chloride) master batch, 10 to 20 parts of TPU (Thermoplastic Polyurethane) master batch, 1 to 2 parts of plasticizer, 0.5 to 0.8 part of flatting agent, 0.1 to 2 parts of yellowing-resistant modifier and 0.1 to 2 parts of modified flame retardant, sym-triazine cyanuric chloride and a benzotriazole intermediate in the anti-yellowing modifier absorb ultraviolet rays and reduce yellowing of the ultraviolet rays on the composite material, and maleimide groups, maleic anhydride and isocyanurate rings for increasing the crosslinking density cooperate with one another, so that the heat resistance of the material is improved, and the yellowing is reduced; phosphorus and nitrogen main chains of phosphonitrilic chloride trimer in the modified flame retardant have a conjugation effect, so that a protective film is formed, oxygen is isolated, and the phosphonitrilic chloride trimer and nitrogen are synergistically flame-retardant; the anti-yellowing automobile composite film prepared by the invention not only has excellent ultraviolet absorption performance, heat resistance and anti-yellowing effects, but also has a good flame retardant effect.

The invention discloses a flame-retardant insulating powder coating for a new energy automobile and a preparation method of the flame-retardant insulating powder coating, and belongs to the technical field of coatings. The flame-retardant insulating powder coating for the new energy automobile is prepared from the following raw material components in parts by mass: 380 to 384 parts of epoxy resin, 56 to 58 parts of a toughening agent, 5 to 10 parts of modified flame-retardant filler, 100 to 101 parts of a composite curing agent, 5 parts of a flatting agent, 1 part of benzoin and 0.7 part of an accelerant, the toughening agent is obtained by carrying out a reaction on an isophorone diisocyanate tripolymer, 4-bromophenol and N-p-coumaroyl tyramine; the modified flame-retardant filler is obtained by firstly wrapping hexagonal boron nitride with polydopamine and then modifying with a silane coupling agent; the silane coupling agent is obtained by combining 4-benzonitrile oxygen butyl trimethoxy silane and a sulfydryl silane coupling agent; and the composite curing agent is obtained by combining 4, 4-diaminodiphenylmethane and amino-sulfydryl functional organic polysiloxane.

The invention relates to the field of cables, and discloses a modified polyvinyl chloride composite material for cables and a preparation method thereof.The composite material comprises low-density polyethylene, polyvinyl chloride, ethylene-vinyl acetate copolymer, nitrile rubber, modified graphene oxide, modified nano calcium carbonate and auxiliaries; the modified graphene oxide is prepared by reacting acylating chlorination of graphene oxide with an anti-aging derivative, the anti-aging derivative is prepared by reducing a benzoxazole-containing intermediate generated by a reaction of 2-amino-4-bromophenol and 4-cyanobenzaldehyde to obtain an aminated benzoxazole-containing intermediate, then the aminated benzoxazole-containing intermediate reacts with p-phenylenediamine, and then the product reacts with 3-(3, 4-dichlorophenyl)-1, 2, 3-triazole-3-one to obtain the anti-aging graphene oxide. 2, 5-di-tert-butyl-4-hydroxyphenyl) propionyl chloride is subjected to a reaction to prepare the product. And the modified nano calcium carbonate is prepared by reacting phosphonitrilic chloride trimer with an amino silane coupling agent and 2-amino benzoxazole-5-borate and then grafting on the surface of the nano calcium carbonate. The composite material prepared by the invention has excellent flame retardance, heat resistance and long-acting oxidation resistance.

The invention discloses an antistatic polyester fiber and a preparation method thereof, and relates to the field of fibers. When the antistatic polyester fiber is prepared, N, N-dimethylethanolamine reacts with allyl chloride, and then dichloro phthalocyanine silicon is grafted to obtain modified silicon phthalocyanine; polymerizing terephthalic acid, itaconic acid and ethylene glycol, and reacting with fluorescein isothiocyanate and modified silicon phthalocyanine in sequence to obtain modified polyester chips; the preparation method comprises the following steps: reacting phosphonitrilic chloride trimer with 3-hydroxy-5-nitropyridazine, and reducing to obtain a flame retardant; and carrying out melt spinning on the modified polyester chips and a flame retardant, and reacting to obtain the antistatic polyester fiber. The antistatic polyester fiber prepared by the invention has excellent antistatic property, antibacterial property, flame retardance and mechanical property.

The invention discloses a novel coronavirus neutralizing antibody, a detection kit and application of the novel coronavirus neutralizing antibody. The amino acid sequence of a heavy chain variable region of the neutralizing antibody is shown as SEQ ID No.1, and the amino acid sequence of a light chain variable region of the neutralizing antibody is shown as SEQ ID No.2. The antibody with mature affinity is screened through bioinformatics analysis of a single B cell, the antibody screening process is optimized by combining single cell RNA sequencing, VDJ rearrangement analysis and somatic cell hypermutation research, blindness of a traditional method is avoided, and the accuracy and effectiveness of antibody screening are improved. According to the neutralizing antibody GR12 provided by the invention, a heavy chain variable region and a light chain variable region of the neutralizing antibody GR12 can be specifically combined with an RBD structural domain of the SARS-CoV-2 and an S-Trimer structural domain of an Omicro variant, so that a broad-spectrum neutralizing effect on the SARS-CoV-2 virus and the variant thereof is realized. The binding activity of the antibody GR12 to S-Trimer and RBD under 2-fold and 300-fold dilution conditions is obviously superior to that of other antibodies, which indicates that the antibody GR12 has high affinity and dilution stability and is suitable for clinical large-dose administration.

The invention discloses a CD40L-IL-2 fusion protein, preparation thereof and application of the CD40L-IL-2 fusion protein in preparation of drugs for treating tumors. The fusion protein comprises a CD40L trimer or a variant thereof, and a cytokine IL-2 or a variant thereof; the CD40L trimer comprises three CD40L monomers which are connected with one another. The fusion protein provided by the invention can synergistically activate APC-dependent antigen presentation and T cell-mediated immune killing to form closed-loop anti-tumor immune response of antigen presentation-immune initiation-effect amplification, and an effective strategy is provided for tumor treatment.

The invention discloses a novel coronavirus neutralizing antibody, a detection kit and application of the novel coronavirus neutralizing antibody. The amino acid sequence of a heavy chain variable region of the neutralizing antibody is shown as SEQ ID No.1, and the amino acid sequence of a light chain variable region of the neutralizing antibody is shown as SEQ ID No.2. The antibody with mature affinity is screened through bioinformatics analysis of a single B cell, the antibody screening process is optimized by combining single cell RNA sequencing, VDJ rearrangement analysis and somatic cell hypermutation research, blindness of a traditional method is avoided, and the accuracy and effectiveness of antibody screening are improved. According to the neutralizing antibody GR75 provided by the invention, a heavy chain variable region and a light chain variable region of the neutralizing antibody GR75 can be specifically combined with an RBD structural domain of the SARS-CoV-2 and an S-Trimer structural domain of an Omicro variant, so that a broad-spectrum neutralizing effect on the SARS-CoV-2 virus and the variant thereof is realized. The binding activity of the antibody GR75 to S-Trimer and RBD under 2-fold and 300-fold dilution conditions is obviously superior to that of other antibodies, which indicates that the antibody GR75 has high affinity and dilution stability and is suitable for clinical large-dose administration.

The invention discloses a novel coronavirus neutralizing antibody GR46, a detection kit and application of the novel coronavirus neutralizing antibody GR46. The amino acid sequence of a heavy chain variable region of the neutralizing antibody is shown as SEQ ID No.1, and the amino acid sequence of a light chain variable region of the neutralizing antibody is shown as SEQ ID No.2. The antibody with mature affinity is screened through bioinformatics analysis of a single B cell, the antibody screening process is optimized by combining single cell RNA sequencing, VDJ rearrangement analysis and somatic cell hypermutation research, blindness of a traditional method is avoided, and the accuracy and effectiveness of antibody screening are improved. According to the neutralizing antibody GR46 provided by the invention, a heavy chain variable region and a light chain variable region of the neutralizing antibody GR46 can be specifically combined with an RBD structural domain of the SARS-CoV-2 and an S-Trimer structural domain of an Omicro variant, so that a broad-spectrum neutralizing effect on the SARS-CoV-2 virus and the variant thereof is realized. The binding activity of the antibody GR46 to S-Trimer and RBD under 2-time and 300-time dilution conditions is obviously superior to that of other antibodies, which indicates that the antibody GR46 has high affinity and dilution stability and is suitable for clinical large-dose administration.

The invention relates to the technical field of virology, immunology and biomedicine, in particular to a human metapneumovirus F protein mutant and application thereof. The human metapneumovirus F protein mutant provided by the invention has stable prefusion conformation and high expression quantity, and can form a stable trimer, so that the human metapneumovirus F protein mutant can be used for HMPV vaccine development. The F protein mutant provided by the invention has excellent immunogenicity, and can induce excellent immune response when being used together with an HA201 composite adjuvant (QS21 + MPL liposome).

The invention belongs to the field of veterinary drugs, and relates to an avian infectious bronchitis virus antigen recombinant protein S-Trimer and a subunit vaccine thereof. The invention provides an avian infectious bronchitis virus antigen recombinant protein S-Trimer. The amino acid sequence of the antigen recombinant protein S-Trimer is as shown in SEQ ID No. 4. The invention provides an infectious bronchitis virus antigen. The infectious bronchitis virus antigen is of a trimer structure of the recombinant protein S-Trimer. The invention provides a chicken infectious bronchitis virus subunit vaccine. The subunit vaccine comprises a pharmaceutically acceptable carrier and an immune dose of the chicken infectious bronchitis virus antigen. The vaccine is high in safety, good in immunogenicity and stable in batches, and can provide complete protection for attacking the infectious bronchitis virus.

The invention discloses an antigen fusion protein and application thereof in preparation of a live vaccine for preventing infectious bursal disease. Specifically disclosed are antigen fusion proteins comprising a VP2 protein, a trimer tag, and a C3d protein. The invention also discloses recombinant Eimeria heap constructed by using the antigen fusion protein and application of the recombinant Eimeria heap in preparation of IBDV live vaccines. The oocyst of the recombinant Eimeria heap can effectively induce humoral immune response aiming at IBDV as a vaccine active ingredient, the level of an induced antibody is obviously higher than that of an insect strain expressed by a single VP2 antigen, viruses can be more effectively neutralized, the immune protection efficacy is improved, the safety is high, and the oocyst has the potential of serving as a live vector genetic engineering vaccine. The IBDV live vaccine can be orally taken through drinking water or feed, vaccination is simple, large-scale immunization of chicken flocks can be achieved, and the IBDV live vaccine is economical and efficient and has a wide prospect of being applied to prevention and control of the IBDV of the chicken flocks.